Treatment doctor tested on himself can put others into remission

Posted on by 3

Castleman Disease patients who do not respond to the only drug currently approved by the FDA may have another option that targets a specific pathway called PI3K/Akt/mTOR.
Source: Science Daily, https://www.sciencedaily.com